Ignite Creation Date:
2024-05-06 @ 6:51 PM
Last Modification Date:
2024-10-26 @ 2:56 PM
Study NCT ID:
NCT05815186
Status:
WITHDRAWN
Last Update Posted:
2024-03-29
First Post:
2023-04-04
Brief Title:
Ladarixin With Sotorasib in Advanced NSCLC - Phase II
Sponsor:
NYU Langone Health
Organization:
NYU Langone Health
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Advanced Non-small Cell Lung Cancer With KRAS G12C Mutation |
Keywords: